Facebook Pixel
 

KISS: Allergy Testing in Primary Care

NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE
KISS Header

BSACI Primary Care Guideline 2025

Background/key principles:

  • References to ‘allergy’ in this guideline refer to immediate/type 1 (IgE-mediated) hypersensitivity reactions.
  • Symptoms occur within minutes/max 1 hour of exposure and include:
    • Rash (urticaria, angioedema or erythema), wheeze, hypotension, vomiting and diarrhoea.
  • Symptoms are REPRODUCIBLE and occur with EVERY subsequent exposure and do NOT occur without exposure to the allergen.
  • Allergy is a CLINICAL diagnosis, and testing should be strictly guided by the clinical history, with tests limited to relevant triggers only; ‘Screening’ allergy testing is not indicated.

Assessment:

  • History is KEY - Use the STAR principles:
    • Are Symptoms consistent with an IgE-mediated mechanism?
    • Is Timing consistent with an IgE-mediated mechanism?
    • Can symptoms be attributed to a likely Allergen?
    • Are symptoms Reproducible?
  • IgE testing should only be undertaken if the answer is ‘yes’ to ALL 4 of the STAR questions above.
  • In most cases, it is rarely necessary to test for more than 5 individual allergy-specific IgEs.

General guidance for allergy testing:

  • Measurement of total IgE is not helpful in allergy testing.
  • Food testing:
    • Do not use bundles of tests, e.g. food mixes - test only the specific food compatible with the allergy.
    • Any suspected food that has been consumed and tolerated after the event can be excluded without testing.
    • Isolated delayed (>1 hour) GI features are generally not consistent with allergy.
  • Inhalant allergies:
    • Always consider non-allergic respiratory disease, including perennial rhinitis, before considering allergy/testing.
    • Timing and duration of symptoms can help identify allergens (click here for a seasonal guide to allergy patterns).
    • Only test if it will change management:
      • If an allergen can't be avoided (e.g. a pollen), testing may not be helpful, but if avoidance is possible (e.g. testing for dog dander), then it probably is helpful.
      • This would include testing if required by local pathways prior to referral to either ENT or allergy clinics.
  • Drug allergies - do not test in primary care; refer to allergy services as per NICE guidance if:
    • Severe reaction, e.g. anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe angioedema or asthmatic reaction.
    • Suspected antibiotic allergy and likely to need that antibiotic in the future, especially beta-lactam antibiotics.
  • Bee and wasp venom:
    • Do not test for local reactions, even if large.
    • If systemic features are present, refer to the allergy clinic; consider baseline mast cell tryptase and IgE wasp and bee venom levels at the point of referral.

Referral:

  • If referring to an allergy clinic, check your local referral guidelines, but information to include in referral:
    • History based on STAR assessment above.
    • Examination findings at the time of the acute event (if available), e.g. RR, pulse, BP.
    • Treatments given and response.
    • Also consider mast cell tryptase levels.
Published on 3rd March 2026

Join us at one of our upcoming courses or live webinars